Ligand Pharmaceuticals Incorporated Shares Outstanding 2009–2025
Ligand Pharmaceuticals Incorporated reported 19.8M of shares outstanding for fiscal 2025. That was 3.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +23.0%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 19.8M | +3.5% |
| FY 2024 | 19.1M | +8.8% |
| FY 2023 | 17.6M | +3.6% |
| FY 2022 | 17.0M | +1.1% |
| FY 2021 | 16.8M | +4.3% |
| FY 2020 | 16.1M | -4.4% |
| FY 2019 | 16.8M | -19.0% |
| FY 2018 | 20.8M | -1.8% |
| FY 2017 | 21.1M | +1.1% |
| FY 2016 | 20.9M | +4.8% |
| FY 2015 | 19.9M | +1.9% |
| FY 2014 | 19.6M | -4.4% |
| FY 2013 | 20.5M | -3.8% |
| FY 2012 | 21.3M | +2.9% |
| FY 2011 | 20.7M | — |
| FY 2010 | 0.0M | — |
| FY 2009 | 0.0M | — |
Source: Ligand Pharmaceuticals Incorporated SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LGND 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Ligand Pharmaceuticals Incorporated reported 19.8M of shares outstanding for fiscal 2025. That was 3.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +23.0%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Ligand Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLigand Pharmaceuticals Incorporated — frequently asked questions
What is Ligand Pharmaceuticals Incorporated's shares outstanding?
Ligand Pharmaceuticals Incorporated (LGND) reported shares outstanding of 19.8M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Ligand Pharmaceuticals Incorporated's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More LGND financial history
Full LGND fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →